Fundamental dimension Equity attribute | BRTPeer $13.24▲+0.23% Cap $248.8MP/E -18.9x QuantScore43/100 | ACREPeer $3.35▲+2.76% Cap $185.9MP/E -44.5x QuantScore35/100 | ARLLeader $16.30▼-0.67% Cap $263.3MP/E 31.6x QuantScore59/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
46/100 |
15/100 |
62/100 |
Valuation Multiples, PEG & DCF upside | 68/100 | 47/100 | 86/100 |
Health Piotroski, Altman Z, leverage & liquidity | 7/100 | 7/100 | 48/100 |
Growth Revenue / earnings growth & margins | 14/100 | 52/100 | 39/100 |
Sentiment Analyst ratings, targets & revisions | 78/100 | 53/100 | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -18.9x | -44.5x | 31.6x |
Forward P/E (next FY) | -17.8x | 13.0x | — |
EV / EBITDA (TTM) | 19.3x | 28.1x | 13.3x |
Price / Sales | 2.5x | 1.9x | 5.2x |
Price / Free Cash Flow | 23.4x | 14.1x | -31.7x |
PEG ratio | 0.58 | 0.00 | 0.12 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | 4 / 9 | 5 / 9 |
Altman Z-Score | 0.29 (Distress) | -0.18 (Distress) | 1.86 (Grey) |
Total debt / equity | 3.17 | 2.58 | 0.35 |
Quick ratio | — | 0.2x | 15.7x |
Interest coverage | 0.5x | 0.4x | -1.0x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +1.5% | +22.5% | +5.7% |
Net income growth YoY | -22.0% | +97.4% | +206.8% |
Gross margin (TTM) | 28.0% | 71.6% | -39.6% |
Operating margin (FY) | 11.4% | 72.4% | -12.9% |
FCF margin (FY) | 6.8% | 23.1% | -11.1% |
5. Trailing price performancePrice change over period |
1M return | -3.4% | -19.3% | +3.6% |
3M return | -11.7% | -26.4% | +10.2% |
6M return | -7.1% | -36.3% | +12.4% |
Year to date | -9.9% | -29.9% | +1.5% |
1Y return | -11.8% | -27.8% | +5.8% |
3Y return | -21.1% | -63.1% | +29.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $63.20 +377.3% upside | $-11.48 -442.6% premium | $46.06 +182.6% upside |
Wall Street consensus target | $21.00 +58.6% · range $21.00–$21.00 | $5.50 +64.2% · range $5.50–$5.50 | — — |
Consensus stance | 80% Buy20% Hold0% Sell | 36% Buy43% Hold21% Sell | — |